SOLV · 10-Q · 2026Q2 · Full report

Product Portfolio Rationalization

Solventum Corp · 2026-08-05 · Importance 34 · Surprise 42

MedSurg growth was partially offset by Solventum’s SKU rationalization program. The rationalization had a larger impact on the Infection Prevention and Surgical Solutions business. The filing does not quantify the associated sales reduction, but identifies the program as a material offset to growth in the segment.